Serological Assays for the Detection and Characterization of Influenza Viruses

is to support the Influenza Division through the testing of human sera via hemagglutination inhibition assay as well as develop a new serology platform that is comparable to hemagglutination inhibition assay. This is Phase I of a a two phased multi-step mandatory down select solicitation. Interest

for Phase I is due to the contracting officer no later than 2:00 PM EST February 21, 2025. The steps in Phase I are as follows: Letter of Interest � offerors shall email POC information to Contracting Officer Proficiency panel will be sent